-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
AbCellera Biologics Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q2 2024.
- AbCellera Biologics Inc. Depreciation for the quarter ending June 30, 2024 was $3.4M, a 13.3% increase year-over-year.
- AbCellera Biologics Inc. Depreciation for the twelve months ending June 30, 2024 was $13.5M, a 21% increase year-over-year.
- AbCellera Biologics Inc. annual Depreciation for 2023 was $12.8M, a 42.5% increase from 2022.
- AbCellera Biologics Inc. annual Depreciation for 2022 was $8.95M, a 103% increase from 2021.
- AbCellera Biologics Inc. annual Depreciation for 2021 was $4.4M, a 90% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)